0001638599-18-001117.txt : 20180920 0001638599-18-001117.hdr.sgml : 20180920 20180920161749 ACCESSION NUMBER: 0001638599-18-001117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180918 FILED AS OF DATE: 20180920 DATE AS OF CHANGE: 20180920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MATHER CHARLES E IV CENTRAL INDEX KEY: 0001563422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38365 FILM NUMBER: 181079649 MAIL ADDRESS: STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP STREET 2: 509 MADISON AVE., SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EYENOVIA, INC. CENTRAL INDEX KEY: 0001682639 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471178401 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8748 TECHNOLOGY WAY CITY: RENO STATE: NV ZIP: 89521 BUSINESS PHONE: 813-766-9539 MAIL ADDRESS: STREET 1: 8748 TECHNOLOGY WAY CITY: RENO STATE: NV ZIP: 89521 4 1 doc4_5697.xml PRIMARY DOCUMENT X0306 4 2018-09-18 0 0001682639 EYENOVIA, INC. EYEN 0001563422 MATHER CHARLES E IV C/O EYENOVIA, INC. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 1 0 0 0 Common Stock, par value $.0001 2018-09-18 4 P 0 1000 4.80 A 5033 D Common Stock, par value $.0001 2018-09-19 4 P 0 3000 4.78 A 8033 D Stock Option (right to buy) 6.20 2028-07-24 Common Stock 4465 4465 D This transaction was executed in multiple trades ranging from $4.75 to $4.7885. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected. The option becomes exercisable on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. /s/ S. Halle Vakani, Attorney-in-Fact 2018-09-20